Literature DB >> 5948627

Splenectomy for idiopathic thrombocytopenic purpura.

G E Block, R Evans, R Zajtchuk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5948627     DOI： 10.1001/archsurg.1966.01320220040006

Source DB:  PubMed          Journal:  Arch Surg        ISSN： 0004-0010


× No keyword cloud information.
  8 in total

1.  Splenectomy for hematological disorders.

Authors:  A Krishna; V Bhatnagar; L S Arya; D K Mitra
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

2.  Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences.

Authors:  Taylor Olmsted Kim; Amanda B Grimes; Susan E Kirk; Megan M Gilbert; Helen D Reed; Kristen A Staggers; Lauryn A Walker; Abinaya Arulselvan; A Sarah Cohen; Michele P Lambert; Jenny M Despotovic
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

3.  Chronic autoimmune thrombocytopenic purpura associated with haemophilia A.

Authors:  M W Mulholland; J R Edson; J P Delaney
Journal:  Postgrad Med J       Date:  1982-12       Impact factor: 2.401

4.  Splenectomy for thrombocytopenia.

Authors:  S I Schwartz
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

5.  Idiopathic thrombocytopenic purpura in childhood.

Authors:  S I Choi; P D McClure
Journal:  Can Med Assoc J       Date:  1967-09-09       Impact factor: 8.262

6.  Serious complications following treatment of chronic idiopathic thrombocytopenic purpura.

Authors:  W Wanachiwanawin; S Visudhiphan; A Piankijagum; S Vatanavicharn
Journal:  Postgrad Med J       Date:  1988-06       Impact factor: 2.401

7.  Late results of splenectomy in hematologic disorders.

Authors:  Y Ogawa; M Kobayashi; M Saku; S Yo; A Iwaki
Journal:  Jpn J Surg       Date:  1974-03

8.  Identification and characterization of anti-platelet antibodies in idiopathic thrombocytopenic purpura patients.

Authors:  N Aghabeigi; N Lindsey; A Zamani; B Shishaeyan
Journal:  Iran J Public Health       Date:  2012-02-29       Impact factor: 1.429
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.